Kanoria Chemicals & Industries Ltd Valuation Shifts Signal Renewed Price Attractiveness

1 hour ago
share
Share Via
Kanoria Chemicals & Industries Ltd has witnessed a significant improvement in its valuation parameters, shifting from an attractive to a very attractive rating. This change reflects a notable recalibration in price-to-earnings and price-to-book value ratios, positioning the micro-cap commodity chemicals firm as a compelling option relative to its peers and historical benchmarks.
Kanoria Chemicals & Industries Ltd Valuation Shifts Signal Renewed Price Attractiveness

Valuation Metrics Show Marked Improvement

Kanoria Chemicals currently trades at a price of ₹141.20, down 2.22% on the day from a previous close of ₹144.40. Despite this slight dip, the stock’s valuation metrics have improved considerably. The price-to-earnings (P/E) ratio stands at 15.44, a figure that is substantially lower than many of its industry peers, signalling a more reasonable price relative to earnings. The price-to-book value (P/BV) ratio is also attractive at 1.08, indicating the stock is trading close to its book value, which is often viewed favourably by value investors.

Other valuation multiples include an enterprise value to EBIT (EV/EBIT) of 24.71 and an enterprise value to EBITDA (EV/EBITDA) of 12.53, which, while higher than some peers, remain within a reasonable range given the company’s growth prospects and sector dynamics. The EV to capital employed ratio is 1.05, and EV to sales is 0.91, both suggesting efficient capital utilisation and sales valuation.

Notably, the PEG ratio is exceptionally low at 0.06, which implies that the stock’s price is very low relative to its earnings growth potential. This metric often attracts investors looking for undervalued growth opportunities.

Comparative Peer Analysis Highlights Relative Attractiveness

When compared with key competitors in the commodity chemicals sector, Kanoria Chemicals stands out for its valuation appeal. For instance, J.G. Chemicals trades at a P/E of 30.13 and an EV/EBITDA of 22.33, both nearly double Kanoria’s multiples. Titan Biotech and Nitta Gelatin are classified as very expensive, with P/E ratios of 58.2 and 17.68 respectively, and EV/EBITDA multiples well above Kanoria’s. Other peers such as I G Petrochemicals and Oriental Aromatics exhibit even more stretched valuations, with P/E ratios soaring into the hundreds.

In contrast, Kanoria’s very attractive valuation grade is supported by its modest P/E and EV/EBITDA ratios, which suggest the stock is undervalued relative to its sector. This is further reinforced by its Mojo Score of 60.0 and a Mojo Grade upgrade from Sell to Hold as of 04 May 2026, reflecting improved market sentiment and fundamental reassessment.

Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!

  • - Expert-scrutinized selection
  • - Already delivering results
  • - Monthly focused approach

Get Next Month's Pick →

Financial Performance and Returns Contextualise Valuation

Kanoria Chemicals’ return profile over various time horizons provides additional context to its valuation. Year-to-date (YTD), the stock has surged 84.24%, vastly outperforming the Sensex, which has declined 8.36% over the same period. Over one year, Kanoria has delivered a 58.07% return compared to the Sensex’s negative 3.81%. However, over longer periods such as five years, the stock has underperformed the benchmark, with a negative 24.43% return versus the Sensex’s 48.51% gain. The 10-year return of 104.79% also trails the Sensex’s 178.39% appreciation.

This mixed long-term performance suggests that while Kanoria Chemicals has recently gained momentum, it remains a micro-cap stock with inherent volatility and cyclical exposure typical of the commodity chemicals sector.

Operationally, the company’s return on capital employed (ROCE) is modest at 4.26%, and return on equity (ROE) stands at 6.97%. These figures indicate moderate profitability and capital efficiency, which may explain the cautious upgrade to a Hold rating rather than a more bullish stance.

Price Movements and Trading Range

Kanoria Chemicals’ current trading price of ₹141.20 is closer to its 52-week high of ₹162.45 than its 52-week low of ₹55.72, reflecting a strong recovery in the past year. The stock’s intraday range on 03 Aug 2026 was between ₹137.20 and ₹144.40, showing some volatility but overall resilience near recent highs.

Despite the recent 2.22% decline on the day, the stock’s valuation improvement and relative price strength suggest that investors are beginning to recognise its potential value, especially given the very attractive P/E and P/BV ratios compared to peers.

Outlook and Investment Considerations

Kanoria Chemicals & Industries Ltd’s shift to a very attractive valuation grade signals a potential entry point for investors seeking value in the commodity chemicals space. The low PEG ratio and reasonable P/E multiple relative to peers provide a compelling case for further analysis. However, the company’s moderate profitability metrics and micro-cap status warrant a cautious approach.

Investors should weigh the recent strong returns and valuation appeal against the sector’s cyclicality and the company’s historical underperformance over longer periods. The Hold rating and Mojo Score of 60.0 reflect this balanced view, suggesting that while the stock is no longer a sell, it may not yet warrant a strong buy recommendation.

Is Kanoria Chemicals & Industries Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Conclusion

Kanoria Chemicals & Industries Ltd’s recent valuation upgrade to very attractive, driven by a P/E of 15.44 and P/BV of 1.08, marks a significant shift in its market perception. The stock’s relative undervaluation compared to peers and its strong recent returns highlight its potential as a value proposition within the commodity chemicals sector. Nevertheless, investors should remain mindful of the company’s moderate profitability and micro-cap risks, balancing optimism with prudence.

As the company continues to navigate sector dynamics and capitalise on growth opportunities, its valuation metrics will remain a key focus for market participants assessing its investment merit.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News